BGA — BioNeutra Global Balance Sheet
0.000.00%
Consumer DefensivesHighly SpeculativeMicro Cap
Annual balance sheet for BioNeutra Global, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.523 | 0.934 | 0.839 | 0.723 | 1.89 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3.3 | 1.64 | 1.73 | 1.1 | 1.22 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 20.6 | 12.5 | 10.9 | 9.71 | 6.97 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 12.3 | 10.6 | 9.75 | 9.64 | 8.47 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 34 | 23.7 | 21.1 | 19.8 | 15.8 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 22.5 | 16.6 | 15.8 | 16.9 | 14.8 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 29.3 | 23 | 22.1 | 23.5 | 22 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 4.75 | 0.701 | -1.03 | -3.76 | -6.19 |
| Total Liabilities & Shareholders' Equity | 34 | 23.7 | 21.1 | 19.8 | 15.8 |
| Total Common Shares Outstanding |